semaglutide to tirzepatide conversion GLP-1 dose chart and safe switching guide Microdosing Tirzepatide Chart - Gift

Semaglutide is a GLP-1 receptor agonist while tirzepatide activates both GIP and GLP-1 receptors, which can lead to larger average weight loss in some trials

[1] [2] Keep your medication visibleperhaps in a designated spot in your refrigeratorrather than hidden away where it might be forgotten

With insulin: Victoza is approved for use alongside basal insulin in patients with type 2 diabetes

Rather than mimicking gut hormones to suppress appetite, it stimulates the pituitary gland to produce and release more natural growth hormone

FDA Mounjaro label 2026 Approvals breadth edge: semaglutide Semaglutide currently holds more FDA indications including proven cardiovascular benefit, adolescent use, an oral formulation, and the newly approved MASH indication giving it an advantage in breadth of clinical application

Legal and Safety Information Pondok Peptides provides Retatrutide Research Peptide (Lyophilised, HPLC 99%) strictly for scientific and research use